Skip to content
Bacitracin
Baci-rx, Baciguent, Cortisporin, Lanabiotic, Lumi-sporyn, Mycitracin, Ocumycin, Polysporin, Ziba-rx (bacitracin) is a protein pharmaceutical. Bacitracin was first approved as Bacitracin on 1982-01-01. It is used to treat bacterial eye infections, bacterial skin diseases, empyema, pneumonia, and pseudomembranous enterocolitis amongst others in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
digestive system diseasesD004066
respiratory tract diseasesD012140
eye diseasesD005128
skin and connective tissue diseasesD017437
signs and symptoms pathological conditionsD013568
Trade Name
FDA
EMA
Combinations
Lumi-sporyn (generic drugs available since 1982-01-01, discontinued: Cortisporin, Lanabiotic, Mycitracin, Neo-polycin, Ocumycin, Polysporin)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Bacitracin
+
Polymyxin b sulfate
Tradename
Company
Number
Date
Products
LANABIOTICCombeN-050598 DISCN1986-09-22
1 products
Hide discontinued
Bacitracin zinc
+
Hydrocortisone
+
Neomycin sulfate
+
Polymyxin b sulfate
Tradename
Company
Number
Date
Products
CORTISPORINCasper PharmaN-050416 DISCN1982-01-01
1 products, RLD
CORTISPORINMonarch PharmaceuticalsN-050168 DISCN1984-05-04
1 products, RLD
Hide discontinued
Bacitracin zinc
+
Neomycin sulfate
+
Polymyxin b sulfate
Tradename
Company
Number
Date
Products
LUMI-SPORYNCasper PharmaN-050417 RX1982-01-01
1 products, RLD
Bacitracin zinc
+
Polymyxin b sulfate
Tradename
Company
Number
Date
Products
POLYSPORINGSKN-050167 DISCN1985-03-01
1 products
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
baciguentANDA2020-08-26
care science essential first aidOTC monograph not final2023-06-19
cortisporin tcNew Drug Application2019-01-15
neo-polycinANDA2012-09-26
polysporin first aid antibioticOTC monograph final2020-10-23
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
bacterial eye infections—D015818—
bacterial skin diseases—D017192—
empyemaEFO_0003097D004653—
pneumoniaEFO_0003106D011014J18
pseudomembranous enterocolitisEFO_1001314D004761A04.7
staphylococcal infections—D013203A49.01
streptococcal infectionsEFO_1001476D013290—
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
D: Dermatologicals
— D06: Antibiotics and chemotherapeutics for dermatological use
— D06A: Antibiotics for topical use
— D06AX: Other antibiotics for topical use in atc
— D06AX05: Bacitracin
J: Antiinfectives for systemic use
— J01: Antibacterials for systemic use
— J01X: Other antibacterials in atc
— J01XX: Other antibacterials in atc
— J01XX10: Bacitracin
R: Respiratory system drugs
— R02: Throat preparations
— R02A: Throat preparations
— R02AB: Antibiotic throat preparations
— R02AB04: Bacitracin
HCPCS
No data
Clinical
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameBACITRACIN
INNbacitracin
Description
Bacitracin is a mixture of related cyclic peptides produced by organisms of the licheniformis group of Bacillus subtilis var Tracy, first isolated in 1945. These peptides disrupt Gram-positive bacteria by interfering with cell wall and peptidoglycan synthesis.
Classification
Protein
Drug class—
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CC[C@H](C)[C@H](N)C1=N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H]2CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](Cc3cnc[nH]3)NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCCN)NC2=O)[C@@H](C)CC)CS1
Identifiers
PDB—
CAS-ID22601-59-8
RxCUI—
ChEMBL IDCHEMBL1200558
ChEBI ID35862
PubChem CID439542
DrugBankDB00626
UNII ID58H6RWO52I (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 14,073 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
23 adverse events reported
View more details